{"denoms":[{"counts":[{"groupId":"BG000","value":"83"}],"units":"Participants"}],"groups":[{"description":"200 mg/day Thalidomide + 90 mg Pamidronate OR 4 mg Zometa every 2 weeks for 2 months and then every 4 weeks as maintenance therapy","id":"BG000","title":"Thalidomide + Bisphosphonate"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"9.2","value":"60.0"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"40"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"43"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"}]}